Pulse Biosciences, Inc.
NASDAQ:PLSE
15.19 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||
| Current Assets: | ||||||||||
| Cash & Cash Equivalents
| 44.365 | 61.139 | 28.614 | 12.463 | 6.899 | 51.103 | 3.386 | 2.089 | 3.606 | 7.009 |
| Short Term Investments
| 0 | 0 | 0 | 8.012 | 18.499 | 8.48 | 34.683 | 14.306 | 0 | 0 |
| Cash and Short Term Investments
| 44.365 | 61.139 | 28.614 | 20.475 | 25.398 | 59.583 | 38.069 | 16.395 | 3.606 | 7.009 |
| Net Receivables
| 0 | 0 | 0.061 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 5.824 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 0.963 | 1.008 | 2.131 | 1.864 | 1.005 | 0.779 | 0.412 | 0.268 | 0.044 | 0.022 |
| Total Current Assets
| 45.328 | 62.147 | 36.63 | 22.339 | 26.403 | 60.362 | 38.481 | 16.663 | 3.997 | 7.031 |
| Non-Current Assets: | ||||||||||
| Property, Plant & Equipment, Net
| 8.784 | 10.023 | 11.247 | 11.916 | 7.68 | 2.173 | 2.57 | 0.317 | 0.329 | 0.19 |
| Goodwill
| 2.791 | 2.791 | 2.791 | 2.791 | 2.791 | 2.791 | 2.791 | 2.791 | 2.791 | 2.791 |
| Intangible Assets
| 1.886 | 2.551 | 3.216 | 3.882 | 4.547 | 5.213 | 5.878 | 6.543 | 7.208 | 7.874 |
| Goodwill and Intangible Assets
| 4.677 | 5.342 | 6.007 | 6.673 | 7.338 | 8.004 | 8.669 | 9.334 | 10 | 10.665 |
| Long Term Investments
| 0 | -2.725 | -3.255 | -3.613 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 1.65 | 2.725 | 3.255 | 3.613 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.365 | 0.365 | 0.365 | 0.365 | 0.494 | 0.101 | 0.101 | 0 | 0 | 0.01 |
| Total Non-Current Assets
| 15.476 | 15.73 | 17.619 | 18.954 | 15.512 | 10.278 | 11.34 | 9.651 | 10.328 | 10.865 |
| Total Assets
| 60.804 | 77.877 | 54.249 | 41.293 | 41.915 | 70.64 | 49.821 | 26.314 | 14.325 | 17.896 |
| Liabilities & Equity: | ||||||||||
| Current Liabilities: | ||||||||||
| Account Payables
| 1.836 | 1.573 | 2.904 | 1.717 | 1.963 | 1.272 | 0.782 | 0.265 | 0.262 | 0.033 |
| Short Term Debt
| 1.058 | 1.813 | 1.21 | 0.542 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0.016 | 0 | 0 | 0 | 0 | 0 | 0 | 0.039 |
| Other Current Liabilities
| 3.814 | 2.595 | 4.389 | 5.326 | 2.496 | 1.836 | 1.431 | 0.751 | 0.398 | 0.092 |
| Total Current Liabilities
| 6.708 | 5.981 | 8.519 | 7.585 | 4.459 | 3.108 | 2.213 | 1.016 | 0.66 | 0.165 |
| Non-Current Liabilities: | ||||||||||
| Long Term Debt
| 8.086 | 74.144 | 10.04 | 10.814 | 6.719 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 62.275 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 1.65 | 2.725 | 3.255 | 3.613 | 0 | 0 | 0 | 0 | 0 | 1.657 |
| Other Non-Current Liabilities
| -0 | -65 | -3.255 | -3.613 | 0 | 1.198 | 1.613 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 9.736 | 74.144 | 10.04 | 10.814 | 6.719 | 1.198 | 1.613 | 0.265 | 0.262 | 1.657 |
| Total Liabilities
| 16.444 | 80.125 | 18.559 | 18.399 | 11.178 | 4.306 | 3.826 | 1.016 | 0.66 | 1.821 |
| Equity: | ||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 0.055 | 0.037 | 0.029 | 0.025 | 0.021 | 142.053 | 84.219 | 0.013 | 0.008 | 0.008 |
| Retained Earnings
| -336.915 | -294.705 | -236.2 | -172.54 | -122.689 | -75.718 | -38.173 | -12.606 | -3.088 | -0.277 |
| Accumulated Other Comprehensive Income/Loss
| 0 | -0 | 0 | -0.001 | 0.004 | -0.001 | -0.051 | -0.007 | -0 | 0 |
| Other Total Stockholders Equity
| 381.22 | 292.42 | 271.861 | 195.41 | 153.401 | 0 | 0 | 37.898 | 16.746 | 16.343 |
| Total Shareholders Equity
| 44.36 | -2.248 | 35.69 | 22.894 | 30.737 | 66.334 | 45.995 | 25.298 | 13.665 | 16.074 |
| Total Equity
| 44.36 | -2.248 | 35.69 | 22.894 | 30.737 | 66.334 | 45.995 | 25.298 | 13.665 | 16.074 |
| Total Liabilities & Shareholders Equity
| 60.804 | 77.877 | 54.249 | 41.293 | 41.915 | 70.64 | 49.821 | 26.314 | 14.325 | 17.896 |